243
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Adjusting Quality Control Chart Limits for WBC, RBC, Hb, and PLT Counts to Reduce Daily Control Risks in Hospital Laboratory

, , , ORCID Icon, &
Pages 3039-3049 | Published online: 17 Dec 2020

References

  • Shewhart WA. Economic Control of Quality of Manufactured Product. London: Macmillan And Co Ltd; 1931.
  • Levey S, Jennings ER. The use of control charts in the clinical laboratory. Am J Clin Pathol. 1950;20(11_ts):1059–1066. doi:10.1093/ajcp/20.11_ts.105914783086
  • Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27(3):493–501. doi:10.1093/clinchem/27.3.4937471403
  • Plebani M, Piva E. Erythrocyte sedimentation rate: use of fresh blood for quality control. Am J Clin Pathol. 2002;117(4):621–626. doi:10.1309/QB1G-6FRR-DNWX-BKQ911939738
  • Ezzelle J, Rodriguez-Chavez IR, Darden JM, et al. Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal. 2008;46(1):18–29. doi:10.1016/j.jpba.2007.10.01018037599
  • Berger JO. Statistical Decision Theory and Bayesian Analysis. Springer Science & Business Media; 2013.
  • Carlin BP, Louis TA. Bayes and Empirical Bayes Methods for Data Analysis. Vol. 88 Boca Raton: Chapman & Hall/CRC; 2000.
  • Berger J, Berliner LM. Robust Bayes and empirical Bayes analysis with $ _\epsilon $-contaminated priors. Ann Stat. 1986;14(2):461–486. doi:10.1214/aos/1176349933
  • Casella G. An introduction to empirical Bayes data analysis. Am Stat. 1985;39(2):83–87.
  • Hyltoft Petersen P, Ricos C, Stockl D, et al. Proposed guidelines for the internal quality control of analytical results in the medical laboratory. Eur J Clin Chem Clin Biochem. 1996;34(12):983–1000.8986407
  • Westgard JO. Assuring analytical quality through process planning and quality control. Arch Pathol Lab Med. 1992;116(7):765–769.1497451
  • ISO. ISO, 15189: 2012, Medical Laboratories–Particular Requirements for Quality and Competence. Geneva: ISO; 2012.
  • Cooper G, DeJonge N, Ehrmeyer S, et al. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality. Clin Chem Lab Med. 2011;49(5):793–802. doi:10.1515/CCLM.2011.14921366504
  • Miller W, Erek A, Cunningham TD, Oladipo O, Scott MG, Johnson RE. Commutability limitations influence quality control results with different reagent lots. Clin Chem. 2011;57(1):76–83. doi:10.1373/clinchem.2010.14810621097677
  • Ngo A, Gandhi P, Miller WG. Frequency that laboratory tests influence medical decisions. J Appl Lab Med. 2017;1:410–414. doi:10.1373/jalm.2016.021634
  • Hu WY, Yeh CF, Shiao AS, et al. Effects of diagnosis-related group payment on health-care provider behaviors: a consecutive three-period study. J Chin Med Assoc. 2015;78:678–685. doi:10.1016/j.jcma.2015.06.01226341451
  • Choi JW, Kim SJ, Park HK, et al. Effects of a mandatory DRG payment system in South Korea: analysis of multi-year nationwide hospital claims data. BMC Health Serv Res. 2019;19:776.31666066
  • World Health Organization. WHO Manual for Organizing a Nati Onal External Quality Assessment Programme for Health Laboratories and Other Testing Sites. Geneva, Switzerland: WHO Press; 2016.
  • Code of federal regulations chapter IV SubchapterGPart 493 SubpartASection 493.17-test categorization. Available from: https://www.ecfr.gov/cgi-bin/text-idx?SID=1248e3189da5e5f936e55315402bc38b&node=pt42.5.493&rgn=div5. Accessed 817, 2020.
  • Kim S, Yun YM, Kim H, et al. The new diagnosis-related group reimbursement system and laboratory test quality in Korea: analysis of external quality assessment results. Healthcare. 2020;8(2):127–137. doi:10.3390/healthcare8020127
  • Kim H, Kim S, Yun YM, et al. Status of quality control for laboratory tests of medical institutions in Korea: analysis of 10 years of data on external quality assessment participation. Healthcare. 2020;8(2):75–82. doi:10.3390/healthcare8020075
  • Shimetani N. Medical reimbursement for diagnostic tests. Expert Rev Pharm Outcomes Res. 2004;4:127–130.
  • Su BG, Chen SF, Yeh SH, et al. Cost evaluation of clinical laboratory in Taiwan’s National Health System by using activity-based costing. Clin Chem Lab Med. 2016;54(11):1753–1758. doi:10.1515/cclm-2016-019327176745
  • Jun JK, Sung NY, Song SH, et al. Budget impact of the accreditation program for clinical laboratories on colorectal cancer screening via fecal immunochemical testing: results from the national cancer screening program in Korea. Ann Lab Med. 2018;38:249–254. doi:10.3343/alm.2018.38.3.24929401560
  • Inal TC, Goruroglu Ozturk O, Kibar F, et al. A. Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. J Clin Lab Anal. 2018;32(1):e22180. doi:10.1002/jcla.22180
  • Zhang D, Liao M, Liu T. Implementation and promotion of quality control circle: a starter for quality improvement in Chinese hospitals. Risk Manag Healthc Policy. 2020;Volume 13(13):1215–1224. doi:10.2147/RMHP.S261998